HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and tolerance of nisoldipine VS propranolol in patients with essential hypertension.

Abstract
Fifty patients with essential hypertension grade I/II. (WHO) were treated with Nisoldipine (BAY K 5552) or Propranolol for 12 weeks in a single blind, randomised trial. Both drugs similarly reduced mean systolic and diastolic blood pressure. Side effects were rare and usually mild. We conclude that Nisoldipine is safe and effective in the treatment of mild essential hypertension.
AuthorsT Chamiec, B Bednarz, A Budaj, J Kłoś, H Pietrzykowska, T Zaleska, L Ceremuzyński
JournalMateria medica Polona. Polish journal of medicine and pharmacy (Mater Med Pol) 1990 Jul-Sep Vol. 22 Issue 3 Pg. 188-90 ISSN: 0025-5246 [Print] Poland
PMID2132424 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial)
Chemical References
  • Nisoldipine
  • Propranolol
Topics
  • Blood Pressure (drug effects)
  • Heart Rate (drug effects)
  • Humans
  • Hypertension (drug therapy)
  • Middle Aged
  • Nisoldipine (adverse effects, therapeutic use)
  • Propranolol (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: